Authors

Latest:

Dr. Yao Discusses Sources of Information on Decisions Regarding Contralateral Prophylactic Mastectomy

Katharine Yao, MD, director, breast surgical program, NorthShore University HealthSystem, Evanston, Illinois, clinical associate professor, surgery, Pritzker School of Medicine, University of Chicago, discusses a prospective study that analyzed the sources of information regarding decisions on contralateral prophylactic mastectomy.

Katherine C. Rappazzo, MD

Latest:

Oral Anticoagulants Demonstrate Value in Management of Acute VTE

The optimal anticoagulant takes into consideration a variety of components, including patient preference, the indication for anticoagulation, comorbidities, reversibility, and other factors relevant to the clinical scenario.

Katherine Crew, MD, MS

Latest:

Dr. Crew on Treatment in Favorable-Risk HER2+ Breast Cancer

Katherine Crew, MD, MS, discusses treatment for patients with favorable-risk early-stage HER2-positive breast cancer.

Katherine D. Crew, MD, MS

Latest:

Dr. Crew on Recent Advances in HER2+ Breast Cancer

Katherine D. Crew, MD, MS, discusses recent advances made in HER2-positive breast cancer treatment.

Katherine Hasal, MS

Latest:

Novel NGS Test May Enhance Diagnosis and Management of Indeterminate Thyroid Nodules

A next-generation sequencing assay has shown promise as a new tool to aid in the diagnosis and treatment of indeterminate thyroid nodules.

Katherine Krajewski, MD

Latest:

Dr. Krajewski on Responses With PD-1 Agents in RCC

Katherine Krajewski, MD, associate director, physician, Cancer Imaging Program Fellowship, Dana-Farber Cancer Institute, assistant professor of Radiology, Harvard Medical School, discusses the range of responses seen in patients with renal cell carcinoma (RCC) who have received PD-1 agents as treatment.

Katherine Kurnit, MD

Latest:

Dr. Kurnit on Adjuvant Chemotherapy Regimens in Mucinous Ovarian Cancer

Katherine Kurnit, MD, OBGYN oncology fellow at the University of Texas MD Anderson Cancer Center, compares the benefit of gastrointestinal-based versus gynecologic-based adjuvant chemotherapy regimens in patients with mucinous ovarian cancer.

Katherine Van Loon, MD

Latest:

Dr. Van Loon Discusses the Management of Rectal Cancer

Katherine Van Loon, MD, gastrointestinal cancer specialist, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses the management of rectal cancer.

Katherine Virgo, PhD

Latest:

Dr. Virgo Shares the Results of the PCP/MO Barriers Study

Dr. Virgo From American Cancer Society Shares the Results of the PCP/MO Barriers Study

Katherine Yeager, PhD, RN

Latest:

Promoting HPV Vaccination for Girls and Boys

Oncology nurses can lead the way in efforts to protect the next generation from this type of cancer if they know the facts about HPV vaccination for both girls and boys

Kathleen Essel, MD

Latest:

Dr. Essel Discusses Adverse Events of Bevacizumab in Ovarian Cancer

Kathleen Essel, MD, fellow, University of Oklahoma Health Science Center, discusses adverse events with bevacizumab (Avastin) in ovarian cancer.

Kathleen G. Essel, MD

Latest:

Dr. Essel on Rationale to Explore Quantitative CT Image Feature Analysis in Gynecologic Cancers

Kathleen G. Essel, MD, discusses the rationale to explore quantitative computed tomography image feature analysis in gynecologic cancers.

Kathleen Gamblin, RN, BSN, OCN

Latest:

Compassion Fatigue: When Caring Takes Its Toll

Every day, oncology nurses provide care to patients who rely on them not only for their physical care, but also emotional and even spiritual care.

Kathleen L. O'Connor, MD

Latest:

Dr. O'Connor on Ongoing Breast Cancer Research

Kathleen L. O'Connor, MD, professor, associate director of Cancer Education, Department of Molecular and Cellular Biochemistry, University of Kentucky Markey Cancer Center, discusses the ongoing research in the field of breast cancer.

Kathleen M. Foley, MD

Latest:

Dr. Kathleen Foley on the Goal for Cancer Pain Management

Kathleen M. Foley, MD, from Memorial Sloan-Kettering Cancer Center, on the history and future goals for cancer pain management.

Kathleen Madden, FNP, MSN, AOCNP, APHN

Latest:

Using Steroids to Manage Immunotherapy-Associated AEs in Melanoma

Kathleen Madden, FNP, MSN, AOCNP, APHN, discusses how to judiciously use steroids to manage adverse events in patients with melanoma who are receiving immunotherapy.

Kathleen Madden, RN, FNP-BC, AOCNP

Latest:

Kathleen Madden on the Importance of Patient Education

Kathleen Madden, from NYU Langone Medical Center, on the Importance Educating Patients About Ipilimumab's Side Effects.

Kathleen Mahoney, MD, PhD

Latest:

Dr. Mahoney on Potential of VISTA-Targeting Therapy in RCC

Kathleen Mahoney, MD, PhD, discusses the potential of targeting V-domain immunoglobulin containing suppressor of T-cell activation in renal cell carcinoma.

Kathleen Moore, MD

Latest:

Dr Moore on Key 2024 Updates in FRα+ Ovarian Cancer Management

Kathleen Moore, MD, Stephenson Cancer Center

Latest:

Promising Novel Targets for Endometrial Cancer Management